Avidity Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Avidity Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2024.
  • Avidity Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 123M shares, a 66.5% increase year-over-year.
  • Avidity Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 73M shares, a 40% increase from 2022.
  • Avidity Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 52.2M shares, a 25.9% increase from 2021.
  • Avidity Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 41.4M shares, a 91.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 123M +49.3M +66.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 107M +35.5M +49.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 87.2M +16.8M +23.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 73M +20.9M +40% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 74.1M +21M +39.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 71.4M +21.5M +43% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 70.4M +22.2M +46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 52.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 53.1M +9.8M +22.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 49.9M +12.3M +32.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 48.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 43.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 37.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.